ICMC Workshop at the 17th Congress of the ESG, Porto, Portugal, March 20th, 2027

Male Reproductive Health: New Avenues for Male Contraception

Introduction and Chair
Kristina Gemzell-Danielsson (SE) and Logan
Nickels (MCI, USA)

Non-Hormonal methods in the pipeline
Stephanie Page (USA)

Final Results Phase 2b: transdermal NES/T gel
Diana Blithe (USA)

Male Contraceptive Acceptability and Interest:
Steve Kretschmer (USA, TR)

Device approach ADAM
Kevin Eisenfrats (USA)

---

Faculty by alphabetical order:
Diana Blithe, PhD, NICHD, USA; Director of Contraceptive Development Branch at NICHD, NIH
Blithe, Diana (NIH/NICHD)
Kevin S. Eisenfrats; PhD. Co-Founder and CEO of Contraline, Inc.
Kristina Gemzell Danielsson, MD, PhD. Professor of Obstetrics and Gynecology
Professor/Senior Physician | Head of department, Head of Division. Department of Women’s and
Children’s’Health
Steve Kretschmer, Founder, Executive Director; DESIRELine Istanbul | Mbabane | Washington DC
Logan Nickels, PhD; Chief Research Officer; Male Contraceptive Initiative; Durham, North Carolina 27705, US.
Stephanie Page, MD, PhD; Professor of Medicine Chief, Division of Metabolism, Endocrinology and Nutrition Co-
Director, UW Medicine Diabetes Institute. University of Washington School of Medicine, Seattle, WA USA